Sign up to save your podcasts
Or
Share Lixisenatide in Parkinson's: A Diabetes Drug to Slow Disease Progression?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Lixisenatide in Parkinson's: A Diabetes Drug to Slow Disease Progression?
Dr. Michele Matarazzo interviews Dr. Olivier Rascol on the results of the clinical trial recently published in the New England Journal of Medicine. Tune in to learn about the mechanisms of action and potential of lixisenatide and other GLP-1 receptor agonists in impacting the progression of Parkinson's disease.
Read the article »
View all episodes
By International Parkinson and Movement Disorder Society
4.8
99 ratings
Dr. Michele Matarazzo interviews Dr. Olivier Rascol on the results of the clinical trial recently published in the New England Journal of Medicine. Tune in to learn about the mechanisms of action and potential of lixisenatide and other GLP-1 receptor agonists in impacting the progression of Parkinson's disease.
Read the article »
More shows like MDS Podcast
View all
NEJM This Week
319 Listeners
Neurology® Podcast
301 Listeners
Practical Neurology Podcast
49 Listeners
10% Happier with Dan Harris
12,724 Listeners
The Michael J. Fox Foundation Parkinson's Podcast
219 Listeners
The Peter Attia Drive
9,200 Listeners
Neurology Today in 5
24 Listeners
Navigating Neuropsychology
360 Listeners
The Parkinson's Podcast
188 Listeners
Neurology Minute
133 Listeners
Neurology Exam Prep Podcast
181 Listeners
The Lancet Neurology in conversation with
6 Listeners
Movers and Shakers: a podcast about life with Parkinson's
107 Listeners
Continuum Audio
80 Listeners
eanCast: Weekly Neurology
0 Listeners